Full Name
Eng King Tan
Variants
Tan, E.-K.
Tan, E.K.
 
 
 
Email
gmstek@nus.edu.sg
 

Refined By:
Date Issued:  [2000 TO 2009]
Date Issued:  2008

Results 1-20 of 23 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
1Jul-2008Analysis of Lrrk2 R1628P as a risk factor for Parkinson's diseaseRoss, O.A.; Wu, Y.-R.; Lee, M.-C.; Funayama, M.; Chen, M.-L.; Soto, A.I.; Mata, I.F.; Lee-Chen, G.-J.; Chiung, M.C.; Tang, M.; Zhao, Y.; Hattori, N.; Farrer, M.J.; Tan, E.-K. ; Wu, R.-M.
215-Oct-2008Case control MR-CISS and 3D TOF MRA imaging study of medullary compression and hypertension in hemifacial spasmChan, L.-L.; Lee, E.; Fook-Chon, S.; Tan, E.-K. 
32008Case-control study of restless legs syndrome and quality of sleep in Parkinson's diseaseLoo H.-V.; Tan E.-K. 
42008Essential tremor and the common LRRK2 G2385R variantTan E.-K. ; Lee J.; Lim H.-Q. ; Yuen Y.; Zhao Y.
52008Evidence of increased odds of essential tremor in Parkinson's diseaseTan E.-K. ; Lee S.-S.; Fook-Chong S. ; Lum S.-Y.
62008Graves disease and isolated orthostatic tremorTan E.K. ; Lo Y.L. ; Chan L.L. 
72008Growth rate of patient-derived lymphoblastoid cells with LRRK2 mutationsTan E.-K. ; Sie L.; Loong S.
82008Hunting for genes in essential tremorTan E.K. ; Schapira A.H.
92008Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseHaugarvoll K.; Rademakers R.; Kachergus J.M.; Nuytemans K.; Ross O.A.; Gibson J.M.; Tan E.-K. ; Gaig C.; Tolosa E.; Goldwurm S.; Guidi M.; Riboldazzi G.; Brown L.; Walter U.; Benecke R.; Berg D.; Gasser T.; Theuns J.; Pals P.; Cras P.; De Deyn P.P.; Engelborghs S.; Pickut B.; Uitti R.J.; Foroud T.; Nichols W.C.; Hagenah J.; Klein C.; Samii A.; Zabetian C.P.; Bonifati V.; Van Broeckhoven C.; Farrer M.J.; Wszolek Z.K.
10Oct-2008Lrrk2 R1628P in non-Chinese Asian racesTan, E.-K. ; Tang, M.; Tan, L.C.; Wu, Y.-R.; Wu, R.-M.; Ross, O.A.; Zhao, Y.
112008LRRK2 R1628P increases risk of Parkinson's disease: Replication evidenceTan, E.K. ; Tan, L.C.; Lim, H.Q.; Li, R.; Tang, M.; Yih, Y.; Pavanni, R.; Prakash, K.M.; Fook-Chong, S.; Zhao, Y.
12Jul-2008Molecular biology changes associated with LRRK2 mutations in Parkinson's diseaseYi, W.L.; Tan, E.-K. 
1318-Nov-2008Novel ATP13A2 variant associated with Parkinson disease in Taiwan and SingaporeLin, C.H.; Tan, E.K. ; Chen, M.L.; Tan, L.C.; Lim, H.Q.; Chen, G.S.; Wu, R.M.
142008Pathogenicity of LRRK2 P755L variant in Parkinson's diseaseTan E.-K. ; Lim H.-Q.; Yuen Y.; Zhao Y.
152008Spectrum of anxiety symptoms in hyperkinesiasTan E.-K. ; Chan L.-L. 
162008Test-retest repeatability of assessing environmental and lifestyle factors in Parkinson's diseaseYip C.-W.; Tan E.-K. 
172008The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinsons disease, levodopa treatment response, and complicationsBialecka M.; Kurzawski M.; Klodowska-Duda G.; Opala G.; Tan E.-K. ; Drozdzik M.
182008The need for appropriate genotyping strategies for glucocerebrosidase mutations in cohorts with Parkinson disease - ReplyTan E.-K. 
19Aug-2008Treatment outcome correlates with knowledge of disease in hemifacial spasmTan, E.-K. ; Hameed, S.; Fook-Chong, S.; Hussein, K.; Lum, S.-Y.; Chan, L.-L.
202008Uniting Chinese across Asia: The LRRK2 Gly2385Arg risk variantTan E.K. ; Schapira A.H.